The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Abstract
Fanconi anaemia (FA) has recently become an attractive model to study breast cancer susceptibility (BRCA) genes, as three FA genes, FANCD1, FANCN and FANCJ, are identical to the BRCA genes BRCA2, PALB2 and BRIP1. Increasing evidence shows that FA proteins function as signal transducers and DNA-processing molecules in a DNA-damage response network. This network consists of many proteins that maintain genome integrity, including ataxia telangiectasia and Rad3 related protein (ATR), Bloom syndrome protein (BLM), and BRCA1. Now that the gene that is defective in the thirteenth and last assigned FA complementation group (FANCI) has been identified, I discuss what is known about FA proteins and their interactive network, and what remains to be discovered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FA is a rare cancer-prone disease in which patients’ cells are characterized by extreme sensitivity to agents that induce DNA interstrand crosslinks (for review, see [22,23]).”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [23]
Citations
Cites
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N. C., Tutt, A. N. J., & Ashworth, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1457 · Cited by 1,690
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Biallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D., Regel, E., Dinh, C. Q., Sands, A., Gregor Eichele, C., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,087
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Rahman, N., Seal, S., Thompson, D. J., Kelly, P. F., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,026
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,007
Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
Interaction of Human DNA Polymerase η with Monoubiquitinated PCNA
Kannouche, P. L., Wing, J., & Lehmann, A. R. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00259-x · Cited by 845
BRCA2 Function in DNA Binding and Recombination from a BRCA2-DSS1-ssDNA Structure
Yang, H., Jeffrey, P. D., Miller, J. J., Kinnucan, E., Sun, Y., Thomä, N. H., Zheng, N., Chen, P., Lee, W., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.297.5588.1837 · Cited by 719
Flagged first, then by citations
Research works printed but not linked: 1
- Fanconi, G. Familiaere infantile perniziosaartige Anaemie (pernizioeses Blutbild and konstitution). Jahrbuch Kinderheild 117, 257–280 (1927) (in German).
Cited by
Sorted by citations
Items 301–400 of 662
Direct Inhibition of TNF-α Promoter Activity by Fanconi Anemia Protein FANCD2
Matsushita, N., Endo, Y., Sato, K., Kurumizaka, H., Yamashita, T., Takata, M., & Yanagi, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023324 · Cited by 38
A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing
Solomon, P. J., Margaret, P., Rajendran, R., Ramalingam, R., Menezes, G. A., Shirley, A. S., Lee, S. J., Seong, M., Park, S. S., Seol, D., et al. (2015) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-015-0142-6 · Cited by 34
Ubiquitin and SUMO signalling in DNA repair
Thomson, T. M., & Guerra‐Rebollo, M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380116 · Cited by 34
Fanconi Anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments
Kachnic, L. A., Li, L., Fournier, L., & Willers, H. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.11.009 · Cited by 34
The Fanconi anemia/BRCA gene network in zebrafish: Embryonic expression and comparative genomics
Titus, T. A., Yan, Y., WILSON, C. A., Starks, A. M., Frohnmayer, J. D., Bremiller, R., Cañestro, C., Rodríguez‐Marí, A., He, X., & Postlethwait, J. H. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.017 · Cited by 35
The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets
García, M. J., & Benitez, J. J. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0160-6 · Cited by 34
Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
Schuetz, J. M., MacArthur, A. C., Leach, S. R., Lai, A. S., Gallagher, R. P., Connors, J. M., Gascoyne, R. D., Spinelli, J. J., & Brooks-Wilson, A. R. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-117 · Cited by 33
Monitoring a Nuclear Factor-κB Signature of Drug Resistance in Multiple Myeloma
Xiang, Y., Remily-Wood, E. R., Oliveira, V. A., Yarde, D. N., He, L., Cheng, J. Q., Mathews, L., Boucher, K., Cubitt, C. L., Perez, L. E., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.005520 · Cited by 33
RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway
Kim, T. M., Son, M. Y., Dodds, S. G., Hu, L., Luo, G., & Hasty, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1334 · Cited by 33
Genomic Stability: FANCJ-Dependent G4 DNA Repair
Maizels, N. (2008) · Current Biology · doi:10.1016/j.cub.2008.06.011 · Cited by 34
Barroso, E., Pita, G., Arias, J. I., Menéndez, P. R., Zamora, P. M., Blanco, M., Benitez, J. J., & Ribas, G. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0439-5 · Cited by 33
Hereditary breast cancer: from bench to bedside
Grève, J. D., Sermijn, E., Brakeleer, S. D., Ren, Z., & Teugels, E. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283139173 · Cited by 32
It takes two to tango: Ubiquitin and SUMO in the DNA damage response
Bologna, S., & Ferrari, S. M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00106 · Cited by 33
Mutagenic repair of DNA interstrand crosslinks
Shen, X. H., & Li, L. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20558 · Cited by 33
Spinella, J.-F., Healy, J., Saillour, V., Richer, C., Cassart, P., Ouimet, M., & Sinnett, D. (2015) · BMC Cancer · doi:10.1186/s12885-015-1549-6 · Cited by 31
PALB2: a novel inactivating mutation in a Italian breast cancer family
Balìa, C., Sensi, E., Lombardi, G., Roncella, M., Bevilacqua, G., & Caligo, M. A. (2010) · Familial Cancer · doi:10.1007/s10689-010-9382-1 · Cited by 31
FANCC suppresses short telomere-initiated telomere sister chromatid exchange
Rhee, D. B., Wang, Y., Mizesko, M. C., Zhou, F., Haneline, L. S., & Liu, Y. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp556 · Cited by 33
Litim, N., Labrie, Y., Desjardins, S., Ouellette, G., Plourde, K. V., Belleau, P., BRCAs, I., & Durocher, F. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.08.002 · Cited by 32
Constitutive role of the Fanconi anemia D2 gene in the replication stress response
Tian, Y., Shen, X. H., Wang, R., Klages-Mundt, N. L., Lynn, E. J., Martin, S. K., Yin, Y., Gao, M., Chen, J., Schlacher, K., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.814780 · Cited by 31
Impact of inorganic nutrients on maintenance of genomic stability
Cheng, W. (2009) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20489 · Cited by 31
Palagyi, A., Neveling, K., Plinninger, U., Ziesch, A., Targosz, B., Denk, G., Ochs, S., Rizzani, A., Meier, D., Thasler, W. E., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-127 · Cited by 31
MHF1–2/CENP-S-X performs distinct roles in centromere metabolism and genetic recombination
Bhattacharjee, S., Osman, F., Feeney, L., Lorenz, A., Bryer, C., & Whitby, M. C. (2013) · Open Biology · doi:10.1098/rsob.130102 · Cited by 30
RetractedMoving Toward Personalized Medicine
Trainer, A. H., Meiser, B., Watts, K., Mitchell, G., Tucker, K., & Friedlander, M. L. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181dbd1a5 · Cited by 31
Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy
Silvestri, V., Rizzolo, P., Falchetti, M., Zanna, I., Masala, G., Bianchi, S., Palli, D., & Ottini, L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1289-x · Cited by 32
Yuan, F., Qian, L., Zhao, X., Liu, J. Y., Song, L., D’Urso, G., Jain, C., & Zhang, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315366 · Cited by 30
Exploring the link between MORF4L1 and risk of breast cancer
Martrat, G., Maxwell, C. A., Tominaga, E., Porta-de-la-Riva, M., Bonifaci, N., Gómez‐Baldó, L., Bogliolo, M., Lázaro, C., Blanco, I., Brunet, J., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2862 · Cited by 30
FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses
Zhang, F., Fan, Q., Ren, K., Auerbach, A. D., & Andreassen, P. R. (2010) · Chromosoma · doi:10.1007/s00412-010-0285-6 · Cited by 31
Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair
Cantor, S. B., & Xie, J. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20568 · Cited by 29
A new nuclease member of the FAN club
Huang, M., & D'Andrea, A. D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0810-926 · Cited by 29
Cleavage of a model DNA replication fork by a Type I restriction endonuclease
Ishikawa, K., Handa, N., & Kobayashi, I. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp214 · Cited by 29
Stricker, T. P., & KUMAR, V. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0792-2.50012-2 · Cited by 28
The Fanconi anemia pathway promotes DNA glycosylase‐dependent excision of interstrand DNA crosslinks
Macé‐Aimé, G., Couvé, S., Khassenov, B., Rosselli, F., & Saparbaev, M. K. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20548 · Cited by 28
Khalaj, M., Abbasi, A., Yamanishi, H., Akiyama, K., Wakitani, S., Kikuchi, S., Hirose, M., Yuzuriha, M., Magari, M., Degheidy, H. A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.514752 · Cited by 28
Baker, L. A., Holliday, H., & Swarbrick, A. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0196 · Cited by 28
Han, B., Shen, Y., Zhang, P., Panneerselvam, J., Che, R., Zhang, J., Yu, H., & Fei, P. (2017) · Oncotarget · doi:10.18632/oncotarget.14989 · Cited by 28
DNA- and DNA-Protein-Crosslink Repair in Plants
Enderle, J., Dorn, A., & Puchta, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174304 · Cited by 30
Morphological and pathological features of basal-like breast cancer
Botti, G., Cantile, M., Collina, F., Cerrone, M., Sarno, S., Anniciello, A., & Bonito, M. D. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.06.50 · Cited by 27
FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer
Panneerselvam, J., Park, H. K., Zhang, J., Dudimah, F. D., Zhang, P., Wang, H., & Fei, P. (2012) · Cell Cycle · doi:10.4161/cc.21400 · Cited by 28
Structural and functional relationships of FAN1
Jin, H., & Cho, Y. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.06.016 · Cited by 27
Fujinaka, Y., Matsuoka, K., Iimori, M., Tuul, M., Sakasai, R., Yoshinaga, K., Saeki, H., Morita, M., Kakeji, Y., Gillespie, D. A., et al. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.11.005 · Cited by 27
Guo, R., Xu, D., & Wang, W. (2009) · Methods · doi:10.1016/j.ymeth.2009.02.011 · Cited by 27
Self-citationPanneerselvam, J., Pickering, A., Han, B., Li, L., Zheng, J., Zhang, J., Zhang, Y., & Fei, P. (2014) · Oncotarget · doi:10.18632/oncotarget.1796 · Cited by 26
BLM promotes the activation of Fanconi Anemia signaling pathway
Panneerselvam, J., Wang, H., Zhang, J., Che, R., Yu, H., & Fei, P. (2016) · Oncotarget · doi:10.18632/oncotarget.8707 · Cited by 26
A new look at molecular biology of breast cancer
Ma, C., Nepal, M. K., Kim, J., Fan, P., & Fei, P. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1507259 · Cited by 26
Hitting the bull's eye: Novel directed cancer therapy through helicase‐targeted synthetic lethality
Aggarwal, M., & Brosh, R. M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22048 · Cited by 26
Milsom, M. D., Schiedlmeier, B., Bailey, J., Kim, M., Li, D., Jansen, M., Ali, A. M., Kirby, M., Baum, C., Fairbairn, L., et al. (2009) · Blood · doi:10.1182/blood-2008-09-180224 · Cited by 26
A prototypical Fanconi anemia pathway in lower eukaryotes?
McHugh, P. J., Ward, T. A., & Chovanec, M. (2012) · Cell Cycle · doi:10.4161/cc.21727 · Cited by 26
Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression
Blacklock, K. B., Birand, Z., Selmic, L. E., Nelissen, P., Murphy, S., Blackwood, L., Bass, J., McKay, J., Fox, R. I., Beaver, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42839-x · Cited by 26
Rı́o, P., Meza, N. W., González‐Murillo, Á., Navarro, S., Alvarez, L. A., Surrallés, J., Castellà, M., Güenechea, G., Segovia, J. C., Hanenberg, H., et al. (2008) · Blood · doi:10.1182/blood-2008-05-156356 · Cited by 25
Fox, D., Yan, Z., Ling, C., Zhao, Y., Lee, D., Fukagawa, T., Yang, W., & Wang, W. (2014) · Cell Research · doi:10.1038/cr.2014.42 · Cited by 25
Self-citationKuhnert, V. M., Kachnic, L. A., Li, L., Purschke, M., Gheorghiu, L., Lee, R., Held, K. D., & Willers, H. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000902883810 · Cited by 25
O’Connell, M. J. (2010) · Journal of Molecular Evolution · doi:10.1007/s00239-010-9399-y · Cited by 25
Jiang, J., Bellani, M. A., Li, L., Wang, P., Seidman, M. M., & Wang, Y. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01135 · Cited by 25
Involvement of FANCD2 in Energy Metabolism via ATP5α
Panneerselvam, J., Ma, C., Nepal, M. K., Shen, Y., Che, R., Turkson, J., & Fei, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-05150-1 · Cited by 26
Eccles, L. J., Bell, A., & Powell, S. N. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.02.003 · Cited by 25
Wang, C., & Lambert, M. W. (2010) · Biochemistry · doi:10.1021/bi100584c · Cited by 25
Ali, A. M., Kirby, M., Jansen, M., Lach, F. P., Schulte, J., Singh, T. R., Batish, S. D., Auerbach, A. D., Williams, D. A., & Meetei, A. R. (2009) · Human Mutation · doi:10.1002/humu.21032 · Cited by 25
Zhu, B., Yan, K., Li, L., Lin, M., Zhang, S., He, Q., Zheng, D., Yang, H., & Shao, G. (2014) · Oncogene · doi:10.1038/onc.2014.229 · Cited by 25
Distinct roles of stress-activated protein kinases in Fanconi anemia type C–deficient hematopoiesis
Saadatzadeh, M. R., Bijangi‐Vishehsaraei, K., Kapur, R., & Haneline, L. S. (2009) · Blood · doi:10.1182/blood-2008-09-181420 · Cited by 24
Biomarkers and Mechanisms of FANCD2 Function
Willers, H., Kachnic, L. A., Luo, C., Li, L., Purschke, M., Borgmann, K., Held, K. D., & Powell, S. N. (2008) · BioMed Research International · doi:10.1155/2008/821529 · Cited by 24
The ATPase activity of Fml1 is essential for its roles in homologous recombination and DNA repair
Nandi, S., & Whitby, M. C. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks715 · Cited by 24
Fanconi Anemia Core Complex Gene Promoters Harbor Conserved Transcription Regulatory Elements
Meier, D., & Schindler, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022911 · Cited by 24
A senataxin-associated exonuclease SAN1 is required for resistance to DNA interstrand cross-links
Andrews, A. M., McCartney, H. J., Errington, T. M., D’Andrea, A. D., & Macara, I. G. (2018) · Nature Communications · doi:10.1038/s41467-018-05008-8 · Cited by 24
A major switch for the Fanconi anemia DNA damage–response pathway
Wang, W. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1108-1128 · Cited by 24
Self-citationLee, K. Y., Chung, K. Y., & Koo, H. (2010) · DNA repair · doi:10.1016/j.dnarep.2009.12.018 · Cited by 24
Sobh, A., Loguinov, A. V., Stornetta, A., Balbo, S., Tagmount, A., Zhang, L., & Vulpe, C. D. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz037 · Cited by 23
Chen, X., Wilson, J. B., McChesney, P. A., Williams, S. A., Kwon, Y., Longerich, S., Marriott, A. S., Sung, P., Jones, N. J., & Kupfer, G. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.552570 · Cited by 24
Tuul, M., Kitao, H., Iimori, M., Matsuoka, K., Kiyonari, S., Saeki, H., Oki, E., Morita, M., & Maehara, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055361 · Cited by 23
Classification, Molecular Characterization, and the Significance ofPtenAlteration in Leiomyosarcoma
Grossmann, A. H., Layfield, L. J., & Randall, R. L. (2012) · Sarcoma · doi:10.1155/2012/380896 · Cited by 23
A mechanism for 1,4-Benzoquinone-induced genotoxicity
Son, M., Deng, C., Hoeijmarkers, J. H., Rebel, V. I., & Hasty, P. (2016) · Oncotarget · doi:10.18632/oncotarget.10184 · Cited by 23
Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype
Carrera‐Lasfuentes, P., Lanas, Á., Bujanda, L., Strunk, M. H. P., Quintero, E., Santolaria, S., Benito, R., Sopeña, F., Piazuelo, E., Thomson, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16261 · Cited by 23
Regulation of various DNA repair pathways by E3 ubiquitin ligases
Natarajan, C., & Takeda, K. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.204879 · Cited by 25
Wilson, J. B., Blom, E., Cunningham, R., Xiao, Y., Kupfer, G. M., & Jones, N. J. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.04.003 · Cited by 24
Gwon, G. H., Kim, Y., Liu, Y., Watson, A. T., Jo, A., Etheridge, T. J., Yuan, F., Zhang, Y., Kim, Y., Carr, A. M., et al. (2014) · Genes & Development · doi:10.1101/gad.248492.114 · Cited by 23
Yang, H., Zhang, T., Tao, Y., Wu, L., Li, H., Zhou, J., Zhong, C., & Ding, J. (2012) · Structure · doi:10.1016/j.str.2011.12.012 · Cited by 22
Rudland, S. D. S., Platt-Higgins, A. M., Winstanley, J. H. R., Jones, N. J., Barraclough, R., West, C. R., Carroll, J., & Rudland, P. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.022 · Cited by 22
Quality control mechanisms in cellular and systemic DNA damage responses
Ermolaeva, M., Dakhovnik, A., & Schumacher, B. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.12.009 · Cited by 23
Jamsai, D., O’Connor, A. E., DeBoer, K., Clark, B. J., Smith, S. J., Browne, C. M., Bensley, J. G., Merriman, J. A., Yuen, W. S., Koopman, P. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056955 · Cited by 22
Roossink, F., de Jong, S., Wisman, G. B. A., van der Zee, A. G. J., & Schuuring, E. M. D. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0091-7 · Cited by 22
Bosch, P. C., Bogliolo, M., & Surrallés, J. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.02.007 · Cited by 22
Turnover of BRCA1 Involves in Radiation-Induced Apoptosis
Liu, W., Zong, W., Wu, G. Y., Fujita, T., Li, W., Wu, J. Q., & Wan, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014484 · Cited by 24
Lysine Crotonylation: An Emerging Player in DNA Damage Response
Zhao, Y., Hao, S., Wu, W., Li, Y., Hou, K., Liu, Y., Cui, W., Xu, X., & Wang, H. (2022) · Biomolecules · doi:10.3390/biom12101428 · Cited by 22
Ovejero, S., Viziteu, E., Dutrieux, L., Devin, J., Lin, Y., Alaterre, E., Jourdan, M., Basbous, J., Requirand, G., Robert, N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.983181 · Cited by 22
Fanconi anemia protein FANCD2 inhibits TRF1 polyADP-ribosylation through tankyrase1-dependent manner
Lyakhovich, A., Ramírez, M. J., Castellanos‐Martín, A., Castellà, M., Simons, A. M., Parvin, J. D., & Surrallés, J. (2011) · Genome Integrity · doi:10.1186/2041-9414-2-4 · Cited by 23
Fanconi anemia genes in lung adenocarcinoma- a pathway-wide study on cancer susceptibility
Yang, S., Hsiung, C.-N., Li, Y.-J., Chang, G., Tsai, Y.-H., Chen, K., Huang, M.-S., Su, W., Chen, Y.-M., Hsiung, C. A., et al. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0240-9 · Cited by 21
The rise of genomic profiling in ovarian cancer
Previs, R. A., Sood, A. K., Mills, G. B., & Westin, S. N. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1259069 · Cited by 23
A defined role for multiple Fanconi anemia gene products in DNA-damage-associated ubiquitination
Tan, W., & Deans, A. J. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.03.001 · Cited by 21
Uehara, M., Kusaba, T., Ida, T., Nakai, K., Nakata, T., Tomita, A., Uehara-Watanabe, N., Ikeda, K., Kitani, T., YAMASHITA, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61456-7 · Cited by 21
Song, I. Y., Barkley, L. R., Day, T. A., Weiss, R. S., & Vaziri, C. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11900 · Cited by 21
RetractedGenetic instability syndromes with progeroid features
Neveling, K., Bechtold, A., & Hoehn, H. (2007) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-007-0483-x · Cited by 21
Targeting Homologous Recombination Repair in Cancer
Willers, H., Pfäffle, H. N., & Zou, L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-384999-1.10007-1 · Cited by 21
Liu, W., Cao, H., Wang, J., Elmusrati, A., Han, B., Chen, W., Zhou, P., Li, X., Keysar, S. B., Jimeno, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50861-5 · Cited by 21
Quantitative proteomics to decipher ubiquitin signaling
Chen, P., Na, C. H., & Peng, J. (2012) · Amino Acids · doi:10.1007/s00726-012-1286-y · Cited by 21
FancJ/Brip1 helicase protects against genomic losses and gains in vertebrate cells
Kitao, H., Nanda, I., Sugino, R. P., Kinomura, A., Yamazoe, M., Arakawa, H., Schmid, M., Innan, H., Hiom, K. J., & Takata, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01523.x · Cited by 20
Kap, E. J., Seibold, P., Richter, S., Scherer, D., Habermann, N., Balavarca, Y., Jansen, L., Becker, N., Pfütze, K., Popanda, O., et al. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.8 · Cited by 20
Kulkarni, A. S., & Fortunato, E. A. (2011) · Journal of Virology · doi:10.1128/jvi.02514-10 · Cited by 21
Colnaghi, L., Jones, M. V., Cotto-Rios, X. M., Schindler, D., Hanenberg, H., & Huang, T. T. (2010) · Blood · doi:10.1182/blood-2010-07-295758 · Cited by 20
Targeting the Fanconi Anemia Pathway to Identify Tailored Anticancer Therapeutics
Jenkins, C., Kan, J., & Hoatlin, M. E. (2012) · Anemia · doi:10.1155/2012/481583 · Cited by 20
Liang, F., & Jin, F. (2019) · Oncology Letters · doi:10.3892/ol.2019.10046 · Cited by 20
Fan, X., Chen, Y., Zhang, S., He, D., Wei, S.-F., Wang, Q., Pan, H., & Liu, Y. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153689 · Cited by 20
Metadata
- Authors
- Wang, W.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wang, Weidong
- ORCID
- Wang, Weidong
- Venue
- Nature Reviews Genetics
- Published
- 2007-10
- Volume
- 8
- Issue
- 10
- Pages
- 735-748
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W2010216792
- Cited by
- 663
- References
- 107
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 11 · 2023: 5 · 2022: 15 · 2021: 10 · 2020: 17 · 2019: 20 · 2018: 12 · 2017: 28 · 2016: 24 · 2015: 31 · 2014: 40 · 2013: 52 · 2012: 52
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, BRCA genes, DNA damage response, genome stability, BRCA2, FANCJ, FANCI, PALB2, BRIP1, ATR, Bloom syndrome protein, BRCA1, signal transduction, DNA repair, breast cancer susceptibility
- MeSH terms
- Fanconi Anemia Complementation Group N Protein, Animals, Chromatin, DNA, DNA Damage, DNA Repair, DNA-Binding Proteins, Fanconi Anemia, Humans, Nuclear Proteins, Signal Transduction, RNA Helicases, BRCA2 Protein, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review